Effective co-administration of infliximab and etanercept following the failure of sequential anti-TNF agents in a patient with HLA-B27-associated arthropathy

Rheumatology (Oxford). 2006 Oct;45(10):1314-5. doi: 10.1093/rheumatology/kel211. Epub 2006 Jul 11.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / therapeutic use*
  • Drug Therapy, Combination
  • Etanercept
  • HLA-B27 Antigen*
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Infliximab
  • Joint Diseases / drug therapy
  • Joint Diseases / immunology*
  • Male
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • HLA-B27 Antigen
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Etanercept